The present invention is a psychostimulant antagonist or antidepressant in pharmaceutical unit dosage form—with each unit dosage form containing in an effective amount to treat cocaine or amphetamine dependence in an animal or human in which such treatment is indicated and to whom one or more such unit dosage forms are administered—comprising one or more substituted or unsubstituted diphenyl piperidine derivative active agents according to Formula I: including a diastereomer or enantiomer thereof, together with one or more pharmaceutically acceptable excipients or diluents.
Cocaine Antagonist/Antidepressant Pharmaceutical Preparations